Longitudinal Plasma Proteomic Remodeling in Ovarian Cancer

Plasma proteomic signatures enable risk prediction of early retinal neurodegeneration in type 2 diabetes

This multi-cohort prospective observational study by Wei Wang and colleagues investigates circulating plasma protein signatures associated w

New plasma proteomics model improves thrombosis risk prediction in cancer patients and identifies IL-17-driven endothelial activation as therapeutic target

This article presents research by Karagkouni and colleagues who developed a new cancer-associated venous thromboembolism (VTE) prediction mo

Proteomic and phosphoproteomic profiling reveals melanoma cell responses to T cell attack

This study profiles the early proteomic and phosphoproteomic responses of patient-derived melanoma cells when co-cultured with matched autol

Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer

Plasma proteomic signatures of cellular aging predict human disease - Nature Medicine

Una nueva terapia logra atacar el cáncer de ovario reduciendo el daño a las células sanas